Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.

Stock Information for Appili Therapeutics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Appili Therapeutics Inc

Aditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the Acquisition
Appili Therapeutics Announces Second Amendment to Arrangement Agreement
Appili Therapeutics Announces Amendment to Arrangement Agreement and Increase to Bridge Loan
Appili Therapeutics Reports Fiscal Year 2024 Financial and Operational Results
Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.
Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
Researchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.